Shares of Allergy Therapeutics plc (LON:AGY – Get Free Report) traded down 8.9% during mid-day trading on Tuesday . The company traded as low as GBX 5.87 ($0.07) and last traded at GBX 6.25 ($0.08). 478,628 shares traded hands during mid-day trading, an increase of 5% from the average session volume of 454,540 shares. The stock had previously closed at GBX 6.86 ($0.09).
Allergy Therapeutics Trading Down 5.9 %
The stock has a market cap of £307.98 million, a price-to-earnings ratio of -6.04, a PEG ratio of -30.70 and a beta of 1.40. The business has a fifty day simple moving average of GBX 6.72 and a 200 day simple moving average of GBX 5.50. The company has a debt-to-equity ratio of 835.48, a quick ratio of 1.48 and a current ratio of 1.63.
Allergy Therapeutics Company Profile
Allergy Therapeutics is an international commercial biotechnology company focussed on the treatment and diagnosis of allergic disorders, including aluminium free immunotherapy vaccines that have the potential to cure disease. The Group sells proprietary and third party products from its subsidiaries in nine major European countries and via distribution agreements in an additional ten countries.
Read More
- Five stocks we like better than Allergy Therapeutics
- EV Stocks and How to Profit from Them
- Humana Gains Despite Medicare Advantage Losses—What’s the Catch?
- 3 Healthcare Dividend Stocks to Buy
- Buybacks Galore: 3 Mega-Caps Just Approved Billions in Buybacks
- Insider Trades May Not Tell You What You Think
- 3 Beauty Stocks Off to an Ugly Start—Can 1 Stage a Comeback?
Receive News & Ratings for Allergy Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allergy Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
